Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox
Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity.
- Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox
Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity.
- Study Shows Pine Bark Naturally Reduces Osteoarthritis Knee Pain by Inhibition of Cox
Patients who supplemented with pine tree bark extract demonstrated a decrease in pain and inflammation by lowering cyclooxygenase activity.
- Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better
Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats.
- Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better
Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats.
- Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better
Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats.
- New Study On Saw Palmetto Demonstrates Puzzling Results
A new study on saw palmetto’s role in relieving symptoms of benign prostatic hyperplasia, published in the February 9 issue of the New England Journal of Medicine, showed inconsistent conclusions to those found in the existing body of scientific literature on the popular dietary supplement.
- New Study On Saw Palmetto Demonstrates Puzzling Results
A new study on saw palmetto’s role in relieving symptoms of benign prostatic hyperplasia, published in the February 9 issue of the New England Journal of Medicine, showed inconsistent conclusions to those found in the existing body of scientific literature on the popular dietary supplement.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- Study: Popular Herbal Therapy No Better Than Placebo
New England Journal of Medicine double-blind, placebo controlled study examines saw palmetto for Benign Prostatic Hyperplasia (BPH) and finds that after one year, there was no difference in symptom changes between the group taking saw palmetto and those recieiving placebo, contradicting previous research.
- Study: Popular Herbal Therapy No Better Than Placebo
New England Journal of Medicine double-blind, placebo controlled study examines saw palmetto for Benign Prostatic Hyperplasia (BPH) and finds that after one year, there was no difference in symptom changes between the group taking saw palmetto and those recieiving placebo, contradicting previous research.
- Dietary Supplement Industry Claims Saw Palmetto Study Misleading
NNFA points out a number of flaws in New England Journal of Medicine (NEJM) study, specifically a substantial existing body of clinical studies, some with larger patient populations, that support the efficacy of this supplement for mild to moderate symptoms associated with benign prostatic hyperplasia (BPH).
- Dietary Supplement Industry Claims Saw Palmetto Study Misleading
NNFA points out a number of flaws in New England Journal of Medicine (NEJM) study, specifically a substantial existing body of clinical studies, some with larger patient populations, that support the efficacy of this supplement for mild to moderate symptoms associated with benign prostatic hyperplasia (BPH).
- New Saw Palmetto Study Fails to Corroborate Earlier Research
AHPA suggests that new study needs to be considered in the totality of clinical research on saw palmetto, including 2002 meta-analysis of 21 previous studies; notes no difference in risk of serious adverse events in current study.
- New Saw Palmetto Study Fails to Corroborate Earlier Research
AHPA suggests that new study needs to be considered in the totality of clinical research on saw palmetto, including 2002 meta-analysis of 21 previous studies; notes no difference in risk of serious adverse events in current study.
- New Saw Palmetto Study Fails to Corroborate Earlier Research
AHPA suggests that new study needs to be considered in the totality of clinical research on saw palmetto, including 2002 meta-analysis of 21 previous studies; notes no difference in risk of serious adverse events in current study.
- New Saw Palmetto Study Fails to Corroborate Earlier Research
AHPA suggests that new study needs to be considered in the totality of clinical research on saw palmetto, including 2002 meta-analysis of 21 previous studies; notes no difference in risk of serious adverse events in current study.
- Dried Cranberries Get ‘Healthy’ Regognition
Research from Brigham and Women’s Hospital (BWH) in Boston, using Ocean Spray Craisins®, tested the urine of five women with culture-confirmed urinary tract infection, and have determined that the sweetened dried cranberries correlated with an increase as high as 50 per cent in anti-adherence activity that keeps certain E. coli bacteria from causing infection by adhering to the urinary tract.
- Dried Cranberries Get ‘Healthy’ Regognition
Research from Brigham and Women’s Hospital (BWH) in Boston, using Ocean Spray Craisins®, tested the urine of five women with culture-confirmed urinary tract infection, and have determined that the sweetened dried cranberries correlated with an increase as high as 50 per cent in anti-adherence activity that keeps certain E. coli bacteria from causing infection by adhering to the urinary tract.
- Dried Cranberries Get ‘Healthy’ Regognition
Research from Brigham and Women’s Hospital (BWH) in Boston, using Ocean Spray Craisins®, tested the urine of five women with culture-confirmed urinary tract infection, and have determined that the sweetened dried cranberries correlated with an increase as high as 50 per cent in anti-adherence activity that keeps certain E. coli bacteria from causing infection by adhering to the urinary tract.
- Dried Cranberries Get ‘Healthy’ Regognition
Research from Brigham and Women’s Hospital (BWH) in Boston, using Ocean Spray Craisins®, tested the urine of five women with culture-confirmed urinary tract infection, and have determined that the sweetened dried cranberries correlated with an increase as high as 50 per cent in anti-adherence activity that keeps certain E. coli bacteria from causing infection by adhering to the urinary tract.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- WHI Study Shows Unexpected Outcomes for Calcium and Vitamin D
Two major studies published in the February 16 issue of the New England Journal of Medicine on the role of calcium and vitamin D supplementation in the health of post-menopausal women showed disappointing outcomes inconsistent with the large body of scientific evidence and the prevailing wisdom about the beneficial effects of these two nutrients. One study assesses calcium and vitamin D supplementation on the risk of fractures, and the other on these nutrients’ effects on the risk of colorectal cancer
- WHI Study Shows Unexpected Outcomes for Calcium and Vitamin D
Two major studies published in the February 16 issue of the New England Journal of Medicine on the role of calcium and vitamin D supplementation in the health of post-menopausal women showed disappointing outcomes inconsistent with the large body of scientific evidence and the prevailing wisdom about the beneficial effects of these two nutrients. One study assesses calcium and vitamin D supplementation on the risk of fractures, and the other on these nutrients’ effects on the risk of colorectal cancer
- WHI Study Shows Unexpected Outcomes for Calcium and Vitamin D
Two major studies published in the February 16 issue of the New England Journal of Medicine on the role of calcium and vitamin D supplementation in the health of post-menopausal women showed disappointing outcomes inconsistent with the large body of scientific evidence and the prevailing wisdom about the beneficial effects of these two nutrients. One study assesses calcium and vitamin D supplementation on the risk of fractures, and the other on these nutrients’ effects on the risk of colorectal cancer
- WHI Study Shows Unexpected Outcomes for Calcium and Vitamin D
Two major studies published in the February 16 issue of the New England Journal of Medicine on the role of calcium and vitamin D supplementation in the health of post-menopausal women showed disappointing outcomes inconsistent with the large body of scientific evidence and the prevailing wisdom about the beneficial effects of these two nutrients. One study assesses calcium and vitamin D supplementation on the risk of fractures, and the other on these nutrients’ effects on the risk of colorectal cancer
- WHI Study Shows Unexpected Outcomes for Calcium and Vitamin D
Two major studies published in the February 16 issue of the New England Journal of Medicine on the role of calcium and vitamin D supplementation in the health of post-menopausal women showed disappointing outcomes inconsistent with the large body of scientific evidence and the prevailing wisdom about the beneficial effects of these two nutrients. One study assesses calcium and vitamin D supplementation on the risk of fractures, and the other on these nutrients’ effects on the risk of colorectal cancer
- NNFA Notes That Positive Effects of Calcium Overshadowed in NEJM Study
Association points out that findings in the study show that women who adhered to the regimen (i.e., took what the study called for), were over 60 and thus at higher risk, and who were not already taking calcium, saw a significant benefit from the calcium and vitamin D supplementation.
- NNFA Notes That Positive Effects of Calcium Overshadowed in NEJM Study
Association points out that findings in the study show that women who adhered to the regimen (i.e., took what the study called for), were over 60 and thus at higher risk, and who were not already taking calcium, saw a significant benefit from the calcium and vitamin D supplementation.
- Study Suggests Metagenics' FirstLine Therapy Lifestyle Program Better Than AHA Diet to Reduce Cardiovascular Disease Risks in Postmenopausal Women
February issue of the journal Nutrition (Vol. 22(2), pp. 104-113) features the results of a 2-arm prospective clinical trial in postmenopausal women at risk for cardiovascular disease (CVD), suggesting that patients exhibited a greater improvement in established cardiovascular health markers when comparing Metagenics' FirstLine Therapy(R) therapeutic lifestyle program (FLT) -- to a standard American Heart Association dietary plan (AHAD) and exercise.
- Study Suggests Metagenics' FirstLine Therapy Lifestyle Program Better Than AHA Diet to Reduce Cardiovascular Disease Risks in Postmenopausal Women
February issue of the journal Nutrition (Vol. 22(2), pp. 104-113) features the results of a 2-arm prospective clinical trial in postmenopausal women at risk for cardiovascular disease (CVD), suggesting that patients exhibited a greater improvement in established cardiovascular health markers when comparing Metagenics' FirstLine Therapy(R) therapeutic lifestyle program (FLT) -- to a standard American Heart Association dietary plan (AHAD) and exercise.
- Study Suggests Metagenics' FirstLine Therapy Lifestyle Program Better Than AHA Diet to Reduce Cardiovascular Disease Risks in Postmenopausal Women
February issue of the journal Nutrition (Vol. 22(2), pp. 104-113) features the results of a 2-arm prospective clinical trial in postmenopausal women at risk for cardiovascular disease (CVD), suggesting that patients exhibited a greater improvement in established cardiovascular health markers when comparing Metagenics' FirstLine Therapy(R) therapeutic lifestyle program (FLT) -- to a standard American Heart Association dietary plan (AHAD) and exercise.
- Study Suggests Metagenics' FirstLine Therapy Lifestyle Program Better Than AHA Diet to Reduce Cardiovascular Disease Risks in Postmenopausal Women
February issue of the journal Nutrition (Vol. 22(2), pp. 104-113) features the results of a 2-arm prospective clinical trial in postmenopausal women at risk for cardiovascular disease (CVD), suggesting that patients exhibited a greater improvement in established cardiovascular health markers when comparing Metagenics' FirstLine Therapy(R) therapeutic lifestyle program (FLT) -- to a standard American Heart Association dietary plan (AHAD) and exercise.
- Study Suggests Metagenics' FirstLine Therapy Lifestyle Program Better Than AHA Diet to Reduce Cardiovascular Disease Risks in Postmenopausal Women
February issue of the journal Nutrition (Vol. 22(2), pp. 104-113) features the results of a 2-arm prospective clinical trial in postmenopausal women at risk for cardiovascular disease (CVD), suggesting that patients exhibited a greater improvement in established cardiovascular health markers when comparing Metagenics' FirstLine Therapy(R) therapeutic lifestyle program (FLT) -- to a standard American Heart Association dietary plan (AHAD) and exercise.
- Study Suggests Metagenics' FirstLine Therapy Lifestyle Program Better Than AHA Diet to Reduce Cardiovascular Disease Risks in Postmenopausal Women
February issue of the journal Nutrition (Vol. 22(2), pp. 104-113) features the results of a 2-arm prospective clinical trial in postmenopausal women at risk for cardiovascular disease (CVD), suggesting that patients exhibited a greater improvement in established cardiovascular health markers when comparing Metagenics' FirstLine Therapy(R) therapeutic lifestyle program (FLT) -- to a standard American Heart Association dietary plan (AHAD) and exercise.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Study Shows Supplements Relieve Osteoarthritis Pain
A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain.
- Herbalife Expands Medical Advisory Board with Appointees in Turkey and Russia
Company announces the appointment of two new members to its Medical Advisory Board (MAB), Ali Kocailik M.D. in Turkey and Alla Pogozheva M.D. in Russia.
- Herbalife Expands Medical Advisory Board with Appointees in Turkey and Russia
Company announces the appointment of two new members to its Medical Advisory Board (MAB), Ali Kocailik M.D. in Turkey and Alla Pogozheva M.D. in Russia.
- Herbalife Expands Medical Advisory Board with Appointees in Turkey and Russia
Company announces the appointment of two new members to its Medical Advisory Board (MAB), Ali Kocailik M.D. in Turkey and Alla Pogozheva M.D. in Russia.
- Herbalife Expands Medical Advisory Board with Appointees in Turkey and Russia
Company announces the appointment of two new members to its Medical Advisory Board (MAB), Ali Kocailik M.D. in Turkey and Alla Pogozheva M.D. in Russia.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- NEJM Study Shows Supplements Relieve Mild Forms of Arthritis
NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain.
- NEJM Study Shows Supplements Relieve Mild Forms of Arthritis
NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain.
- NEJM Study Shows Supplements Relieve Mild Forms of Arthritis
NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain.
- Research Shows Beneo(TM) Promotes Probiotic Vitality
Results of new study indicate that Beneo(TM) protects the probiotics through both storage and digestion.
- Research Shows Beneo(TM) Promotes Probiotic Vitality
Results of new study indicate that Beneo(TM) protects the probiotics through both storage and digestion.
- Research Shows Beneo(TM) Promotes Probiotic Vitality
Results of new study indicate that Beneo(TM) protects the probiotics through both storage and digestion.
- Research Shows Beneo(TM) Promotes Probiotic Vitality
Results of new study indicate that Beneo(TM) protects the probiotics through both storage and digestion.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
- GMP Labs Expands Liquid Nutraceutical Capabilities
- What Parents Should Know About Kids and Supplements
- What Parents Should Know About Kids and Supplements
- Oats Beat Back Cholesterol
- Oats Beat Back Cholesterol
- Seniors: Pump Up for Strong Bones and Heart
- Seniors: Pump Up for Strong Bones and Heart
|
Men who have a diet rich in soya products, beans and sunflower seeds run a much lower risk of contracting prostate cancer. New findings from Karolinska Institutet show that foods rich in phytoestrogens - plant-produced oestrogens - protect against the most common form of cancer in the western world.
Some 10,000 men develop prostate cancer in Sweden each year. Just why prostate cancer is so common is still something of a mystery, but age, ethnicity and genes are usually considered risk factors. However, several studies also show that diet also has an important part to play. Recently, scientists have become interested in the protective effect of oestrogen-like compounds in plants, or phytoestrogens. In countries like China and Japan, people ingest more of these compounds than in the west, and the incidence of prostate cancer is lower. Phytoestrogens are usually divided into two groups: lignans and isoflavones, the former being found mainly in linseed, rye, berries and vegetables, the latter in soya beans.
Scientists at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics have studied the correlation between prostate cancer and phytoestrogen in a large population-based case-control study. Involving 1,499 patients between the ages of 35 and 79 with recently diagnosed prostate cancer, it is the largest study of its kind on a western population. 1,130 healthy controls were identified through a process of matching by age and place of residence. All participants were asked to complete a questionnaire about their dietary habits and to take a blood test. A smaller group (209 cases and 214 controls) had the amount of the phytoestrogen enterolactone in their blood measured.
"The study shows that men who had a high intake of phytoestrogen-rich food, such as beans (which offered the greatest protection), soya products, linseed, sunflower seeds, berries and peanuts, ran a 26 per cent lower risk of developing prostate cancer. We also found that men with very low blood levels of enterolactone had a greater chance of contracting the disease", says Maria Hedelin.
The intake of lignans matches closely that of other western countries, the richest sources being linseed, rye bread, wheat bread, and berries. The intake was low, which can be expected as soya products are not so common in Sweden. In China, where soya beans are much more popular, one study revealed a thousand-fold higher isoflavanoid intake than in our study.
"The protective effect might derive directly from the phytoestrogens alone or in combination with other substances found in the same type of food. We do not, however, recommend the intake of artificial phytoestrogen supplements, as the tablets have not been clinically tested; they also contain high concentrations and can have adverse side-effects."
The results of the study shed light on the intake of phytoestrogens in Sweden. This can be of guidance in studies of other cancer forms that the compounds can be thought to affect. The study also brings us closer to preventative measures and future treatments. Using the genetic information gathered, we will go on to study if there is an interaction between the intake of phytoestrogens from the diet and variations of certain genes in the population that influence the risk of contracting prostate cancer.
Publication: "Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the Cancer Prostate Sweden Study"
Hedelin M, Klint Å, Chang ET, Bellocco R, Johansson J-E, Andersson S-O, Heinonen S-M, Adlercreutz H, Adami H-O, Grönberg H, Augustsson Bälter K.
Cancer Causes and Control, 2006 vol.17 No. 2, 169-180 |